CancerWeb [ CancerWeb Home | Comments | CancerWeb Report Index ]

The CancerWeb Report, What's New In Cancer
Treatment of Bacterial Infections in Chemotherapy Patients: November 1995

Last modified on: Tuesday, April 20, 1999 13:03:12
Copyright © 1994-2008, Information Ventures, Inc.

Treatment of Bacterial Infections in Chemotherapy Patients - The newer chemotherapy treatments are so intensive that patients may have their bone marrows virtually wiped out. They experience a period of very low white counts during which they are especially susceptible to infections that could prove fatal. Three supportive measures are used: bone marrow or blood stem cell transplants; use of growth factors like GM-CSF to stimulate recovery of the ability to make white cells; and intensive antibiotic treatment. Combinations of antibiotics are generally used for severe depletion of white cells. However, infections by gram-positive bacteria are increasing, and these are not well covered by the cephalosporin that is usually part of the combination. While a drug like imipenem-cilastin works well, the very high doses needed in severe conditions, such as in bone marrow transplant recipients, may produce neurological effects, or even seizures. A new broad-spectrum antibiotic, meropenem, even when used alone, was more effective than the conventional combination in children with cancer, according to a large trial in Europe by the International Therapy Cooperative Group of the EORTC and the Italian GIMEMA Infection Programme. The response rate was 90% compared with only 47% for the combination, and just over half the number of children, only 3.7%, experienced side- effects. The results of the study were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy at Case Western Reserve University in October, 1995. The active development and appearance of new antibiotic classes is particularly welcome at this time, when widespread bacterial resistance to current antibiotics is becoming a threat of crisis proportions.



Copyright (c) 1994-2008, Information Ventures, Inc.
Mail us at: Customer-Service@infoventures.com
http://infoventures.com